Literature DB >> 22668239

Review on 4D models for organ motion compensation.

Christine Tanner1, Dirk Boye, Golnoosh Samei, Gabor Szekely.   

Abstract

Minimal invasive tumor therapies are getting ever more sophisticated with novel treatment approaches and new devices allowing for improved targeting precision. Applying these effectively requires precise localization of the structures of interest. Vital processes, such as respiration and heartbeat, induce organ motion, which cannot be neglected during therapy. This review focuses on 4D organ models to compensate for respiratory motion during therapy. An overview is given on the effects of motion on the therapeutical outcome, methods required to capture and quantify respiratory motion, range of reported tumor motion, types of surrogates used when tumors are not directly observable, and methods for temporal prediction of surrogate motion. Organ motion models, which predict the location of structures of interest from surrogates measured during therapy, are discussed in detail.

Entities:  

Mesh:

Year:  2012        PMID: 22668239     DOI: 10.1615/critrevbiomedeng.v40.i2.40

Source DB:  PubMed          Journal:  Crit Rev Biomed Eng        ISSN: 0278-940X


  3 in total

1.  [Ultrasound motion tracking for radiation therapy].

Authors:  J Jenne; J Schwaab
Journal:  Radiologe       Date:  2015-11       Impact factor: 0.635

2.  In vivo validation of spatio-temporal liver motion prediction from motion tracked on MR thermometry images.

Authors:  C Tanner; Y Zur; K French; G Samei; J Strehlow; G Sat; H McLeod; G Houston; S Kozerke; G Székely; A Melzer; T Preusser
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-04-12       Impact factor: 2.924

3.  The 2014 liver ultrasound tracking benchmark.

Authors:  V De Luca; T Benz; S Kondo; L König; D Lübke; S Rothlübbers; O Somphone; S Allaire; M A Lediju Bell; D Y F Chung; A Cifor; C Grozea; M Günther; J Jenne; T Kipshagen; M Kowarschik; N Navab; J Rühaak; J Schwaab; C Tanner
Journal:  Phys Med Biol       Date:  2015-07-02       Impact factor: 3.609

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.